Lotus Eye Hospital & Institute Downgraded to 'Sell' by MarketsMOJO on November 6, 2024.

Nov 06 2024 07:08 PM IST
share
Share Via
Lotus Eye Hospital & Institute, a microcap company in the healthcare industry, has been downgraded to a 'Sell' by MarketsMojo due to flat results and a -58.93% decrease in profits in the past 9 months. Technical factors also indicate a Bearish trend and the stock is trading at a premium. Shareholders may want to consider selling their shares.
Lotus Eye Hospital & Institute, a microcap company in the hospital and healthcare services industry, has recently been downgraded to a 'Sell' by MarketsMOJO on November 6, 2024. This decision was based on several factors, including the company's flat results in June 2024 and a significant decrease in its profits by -58.93% in the past 9 months.

From a technical standpoint, the stock is currently in a Mildly Bearish range and the trend has deteriorated from Sideways on November 6, 2024. The Bollinger Band and KST technical factors also indicate a Bearish trend. Additionally, with a ROE of 3.6, the stock is considered to have an expensive valuation with a 2.4 Price to Book Value. It is currently trading at a premium compared to its average historical valuations.

In the past year, Lotus Eye Hospital & Institute has underperformed the market (BSE 500) with a return of -19.99%, while its profits have fallen by -47.3%. This is in stark contrast to the market's return of 33.50% in the same time period.

On a positive note, the company has a low Debt to Equity ratio (avg) at 0 times, indicating a strong financial position. However, it is worth noting that the majority of shareholders are non-institutional investors.

In conclusion, based on the recent downgrade by MarketsMOJO and the company's underperformance in the market, it may be wise for investors to consider selling their shares in Lotus Eye Hospital & Institute.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Kanani Industries Ltd is Rated Strong Sell
48 minutes ago
share
Share Via
Shiva Texyarn Ltd is Rated Sell
48 minutes ago
share
Share Via
Riba Textiles Ltd is Rated Sell
48 minutes ago
share
Share Via
Piramal Pharma Ltd is Rated Strong Sell
48 minutes ago
share
Share Via
Infibeam Avenues Ltd is Rated Hold
48 minutes ago
share
Share Via